OakChart

Harvard Bioscience Inc

HBIOHealthcare·Medical Instruments & Supplies·USA·Nano·NASD·Nov 11 • 3:59 PM ET

9.68+0.42 (4.54%)
2026-11-12 06:46 CET
Market cap
44.07 USD m
Revenue, TTM
89.41 USD m
Net income, TTM
-11.80 USD m
Free cash flow, TTM
-2.62 USD m
EPS diluted, TTM
-2.62
P/E
-
Compare

Price

HBIO against its 20, 50 and 200-day averages
2050200beatmiss
Patternshover a marker to name it
6.008.0010.0053K105KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HBIOclose 9.6820-day 8.5750-day 8.29200-day 6.559.6852w high

5.1% under the 52-week high of 10.20 on 11 Nov 2026. 52-week low 4.00 on 12 Mar 2026. Last 15 sessions, 25.9% high to low

Volume 4.90× normal · the line is the 50-bar volume average

Profile

HBIO
52-week range, 100% of the way up
4.009.60

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Employees339
IPODec 07, 2000
Beta1.45
ATR, 14d0.48
Rel volume4.90
Short float1.57%
Insider own7.15%
Inst own41.81%

Snapshot

6 groups

Valuation

Index-
Market Cap44.06M
Enterprise Value83.49M
Income-11.80M
Sales89.41M
Book/sh1.12
Cash/sh1.07
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees339
IPODec 07, 2000

Ratios

P/E-
Forward P/E-
PEG-
P/S0.49
P/B8.67
P/C9.07
P/FCF-
EV/EBITDA17.18
EV/Sales0.93
Quick Ratio0.86
Current Ratio1.76
Debt/Eq8.67
LT Debt/Eq8.33
Option/ShortNo / Yes

Earnings

EPS (ttm)-2.62
EPS next Y-0.03
EPS next Q-0.00
EPS this Y-408.33%
EPS next Y97.05%
EPS next 5Y-
EPS past 3/5Y-77.14% -44.59%
Sales past 3/5Y-8.60% -3.25%
EPS Y/Y TTM78.52%
Sales Y/Y TTM2.34%
EPS Q/Q-108.14%
Sales Q/Q7.79%
EarningsNov 10 BMO
EPS/Sales Surpr.81.82% 1.82%

Ownership

Insider Own7.15%
Insider Trans0.00%
Inst Own41.81%
Inst Trans2.88%
ROA-15.40%
ROE-123.13%
ROIC-24.75%
Gross Margin54.24%
Oper. Margin-0.18%
Profit Margin-13.20%
SMA2012.95%
SMA5016.73%
SMA20047.68%
Trades-

Technical

Shs Outstand4.57M
Shs Float4.23M
Short Float1.57%
Short Ratio3.09
Short Interest0.07M
52W High9.60 0.83%
52W Low4.00 142.00%
Volatility9.63% 5.28%
ATR (14)0.48
RSI (14)72.85
Beta1.45
Rel Volume4.90
Avg Volume21.50K
Volume105,448

Performance

Perf Week12.43%
Perf Month17.05%
Perf Quarter45.13%
Perf Half Y73.94%
Perf YTD44.74%
Perf Year59.34%
Perf 3Y-75.80%
Perf 5Y-87.49%
Perf 10Y-62.77%
Recom3.00
Target Price10.25
Prev Close9.26
Price9.68
Change %4.54%

Analyst ratings

latest 10 of 11
DateActionAnalystRating changeTargetImplied
Nov 11, 2026DowngradeSStoneXSpeculative Buy → Hold
Apr 09, 2025DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight
Mar 10, 2023UpgradeTThe Benchmark CompanySpeculative Buy → Buy$3 → $4-58.7%
Jan 07, 2021UpgradeTThe Benchmark CompanySpeculative Buy → Buy
Dec 09, 2020InitiatedNNorthland CapitalOutperform$6-38.0%
Nov 10, 2020InitiatedKKeyBanc Capital MarketsOverweight$6-38.0%
Jul 08, 2019DowngradeJJanneyBuy → Neutral$2-79.3%
Jan 24, 2018ReiteratedJJanneyBuy$5 → $8-17.4%
Jan 23, 2018ReiteratedTThe Benchmark CompanyBuy$6 → $10+3.3%
Nov 17, 2016InitiatedSSingular ResearchBuy$5.50-43.2%

Peers

Mkt cap
TickerCompanyMkt cap
AZTAAzenta Inc2.14B
BNGOBionano Genomics Inc15.37M
LABStandard BioTools Inc253.85M
QTRXQuanterix Corp143.39M
CTKBCytek BioSciences Inc753.32M
BRKRBruker Corp9.53B
SEERSeer Inc88.04M
CRLCharles River Laboratories International Inc16.42B
NAUTNautilus Biotechnology Inc308.24M
MLABMesa Laboratories Inc782.44M

Insider trading

5 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Frost Mark TChief Financial OfficerMar 16 '26Buy5.005,00025,00017,500Apr 01 09:44 AM
DENELSKY STEPHEN JDirectorMar 17 '26Buy4.8710,00048,70021,000Mar 18 02:13 PM
Snider WilliamDirectorMar 16 '26Buy4.9912,52562,50023,525Mar 18 07:31 AM
Snider WilliamDirectorMar 17 '26Buy4.858,47541,10432,000Mar 18 07:31 AM
Duke John DChief Executive OfficerMar 16 '26Buy5.015,00025,050105,000Mar 17 05:56 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFSUDimensional US Sustainability Core 1 ETFAUM: 2.38B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
DXUVUS Vector Equity Portfolio ETF Class SharesAUM: 665.71M
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.65B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.060-0.330-0.58022.2021.803
2026Q22026-08-11-0.140-0.210-0.64322.7321.452
2026Q12026-05-12-0.330-0.620-0.76620.7621.202
2025Q42026-03-120.0000.350-0.63823.7423.102
2025Q32025-11-060.0000.050-0.27620.5920.002
2025Q22025-08-11-0.100-0.250-0.51520.4518.752
2025Q12025-05-12-0.100-0.400-11.41621.7719.202
2024Q42025-03-120.6000.5000.00424.5624.152
2024Q32024-11-07-0.2000.150-1.10121.9723.702
2024Q22024-08-080.0000.500-0.67323.1026.402
2024Q12024-05-070.2000.367-1.08224.5125.803
2023Q42024-03-070.4000.500-0.42628.1529.103
2023Q32023-11-070.1000.400-0.29025.3628.023
2023Q22023-08-080.4000.600-0.23128.7629.501
2023Q12023-04-250.6000.5000.14529.9828.833
2022Q42023-03-090.4000.333-0.39628.4330.333

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY1.2001.400-0.249101.88100.88
2018FY2.0001.967-1.145121.95120.05
2019FY1.8001.867-1.240116.2117
2020FY1.6001.600-2.021102.1102.1
2021FY2.5002.833-0.071118.9118.33
2022FY1.2000.933-2.298113.34115.23
2023FY1.4001.567-0.805112.25113.17
2024FY0.3000.450-2.84994.1493.75
2025FY-0.2000.300-12.80086.5585.90
2026FY--1.017--90.09
2027FY--0.030--94.80
2028FY-0.430--101

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1030024.4324.4024.50
2026Q4S2026-10-3030024.5024.5024.50
2026Q4S2026-08-1120024.5024.5024.50
2026Q4S2026-07-2620024.5024.5024.50
2026Q4S2026-05-2621024.5024.5024.50
2026Q4S2026-05-1221124.5024.5024.50
2026Q4S2026-03-1220224.0523.6024.50
2026Q4S2026-01-0721025.4024.3026.50
2026Q4S2025-11-1220025.2524.0026.50
2026Q4S2025-11-1120025.2524.0026.50
2026Q4S2025-11-1020025.2524.0026.50
2026Q4R2026-11-10302-0.20-0.39-0.08
2026Q4R2026-10-30300-0.16-0.39-0.05
2026Q4R2026-10-25200-0.05-0.05-0.05

Estimate history

EPS, annual-0.249-1.145-1.24-2.021-0.071-2.298-0.805-2.849-12.773-2.6218
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.1010.004-11.416-0.515-0.276-0.638-0.766-0.643-0.575
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual77.407120.774116.176102.1118.904113.335112.2594.13586.5589.41
Period201720182019202020212022202320242025TTM
Sales, quarterly21.9724.55621.77420.4520.59123.73520.75522.72722.196
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual3.5023.7383.8193.9414.1144.2084.3394.4074.4724.573
Period201720182019202020212022202320242025MRQ
Shares, quarterly4.3624.4074.4214.4534.4584.4724.514.5524.573
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue89.4186.5594.14112.25113.33118.90102.10116.18120.77
Cost of Goods Sold Incl. D&A40.9140.6744.5851.3857.1757.0949.7757.6062.98
Gross Profit48.5045.8849.5560.8756.1761.8152.3358.5857.80
Selling, General and Administrative Excl. Other48.6645.7854.1158.5860.8858.4750.0856.7456.81
Research and Development9.228.8210.4111.7612.3310.808.6910.7110.99
Other Operating Expense0.000.000.000.000.060.000.000.000.00
Operating Income-0.160.10-4.562.29-4.773.342.251.840.98
Interest Expense6.964.923.213.592.551.545.155.275.50
Unusual Expense1.4348.683.250.821.461.273.911.463.40
Net Income Before Taxes-12.10-57.39-11.66-2.56-9.18-0.14-7.29-5.50-7.97
Income Taxes-0.30-0.690.740.860.340.150.52-0.81-3.68
Consolidated Net Income-11.80-56.70-12.40-3.42-9.52-0.29-7.81-4.69-4.30
Net Income From Continuing Operations-11.80-56.70-12.40-3.42-9.52-0.29-7.81-4.69-4.30
Net Income-11.80-56.70-12.40-3.42-9.52-0.29-7.81-4.69-4.17
EPS (Recurring)-2.37-5.10-2.33-0.67-2.050.15-1.31-0.97-0.49
EPS (Basic, Before Extraordinaries)-2.62-12.77-2.85-0.81-2.30-0.07-2.02-1.24-1.14
EPS (Diluted)-2.62-12.77-2.85-0.81-2.30-0.07-2.02-1.24-1.14
EBITDA4.866.042.429.282.8010.969.899.578.82
Non-Operating Income (Expense)-3.55-3.89-0.65-0.43-0.40-0.67-0.49-0.61-0.06
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.311.473.433.953.483.042.662.212.40
Price To Sales Ratio0.400.340.982.021.012.391.620.990.96
Gross Margin54.2453.0152.6454.2249.5651.9851.2550.4247.86
Operating Margin-0.180.12-4.842.04-4.212.812.211.580.81
Net Margin-13.20-65.51-13.18-3.04-8.40-0.24-7.65-4.03-3.46
Shares Outstanding4.574.474.414.344.214.113.943.823.74
Market Capitalization44.0744.0793.00228.38115.39290.06169.06116.47118.86

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue22.2022.7320.7523.7320.5920.4521.7724.56
Cost of Goods Sold Incl. D&A10.2510.929.3310.419.4310.0810.7511.80
Gross Profit11.9411.8111.4213.3211.1710.3711.0212.75
Selling, General and Administrative Excl. Other12.4312.4712.3611.3910.9210.9912.4812.53
Research and Development2.262.452.332.182.132.192.322.33
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.49-0.66-0.941.930.24-0.62-1.450.23
Interest Expense1.781.791.731.660.970.790.800.85
Unusual Expense0.660.320.230.220.050.2048.220.22
Net Income Before Taxes-2.69-2.90-3.31-3.20-1.13-2.25-50.790.59
Income Taxes-0.070.010.12-0.360.100.03-0.450.57
Consolidated Net Income-2.62-2.91-3.42-2.85-1.23-2.28-50.340.02
Net Income From Continuing Operations-2.62-2.91-3.42-2.85-1.23-2.28-50.340.02
Net Income-2.62-2.91-3.42-2.85-1.23-2.28-50.340.02
EPS (Recurring)-0.47-0.59-0.73-0.60-0.27-0.48-3.760.04
EPS (Basic, Before Extraordinaries)-0.58-0.64-0.77-0.64-0.28-0.52-11.420.00
EPS (Diluted)-0.58-0.64-0.77-0.64-0.28-0.52-11.420.00
EBITDA0.460.710.413.281.571.000.161.94
Non-Operating Income (Expense)0.24-0.12-0.41-3.25-0.36-0.64-0.321.43
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.340.300.200.460.260.370.470.76
Price To Sales Ratio0.400.320.250.340.220.220.271.00
Gross Margin53.8051.9655.0456.1354.2350.7150.6351.94
Operating Margin-2.22-2.90-4.528.121.19-3.03-6.670.93
Net Margin-11.82-12.80-16.50-11.99-5.98-11.16-231.190.07
Shares Outstanding4.574.554.514.474.464.454.424.41
Market Capitalization44.0727.7421.7829.9119.5519.7625.0293.00

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments8.614.114.284.517.828.328.348.175.19
Short Term Receivables16.0414.8716.1016.7021.8317.7720.7021.4613.38
Inventories20.8023.2524.7226.4427.5922.2622.0625.0916.85
Other Current Assets2.762.903.943.474.343.352.473.1112.11
Total Current Assets48.2345.1249.0451.1261.5851.7053.5757.8347.53
Net Property, Plant & Equipment11.9611.248.759.1810.3111.7213.245.903.74
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets17.2067.4673.1077.2785.0791.7495.79103.0747.61
Deferred Tax Assets3.500.090.440.330.200.260.250.210.18
Other Assets-0.812.746.047.455.170.842.021.6010.28
Total Assets80.07126.64137.37145.36162.34156.25164.87168.61109.35
Short Term Debt Incl. Current Port. of LT Debt1.5238.117.285.955.383.839.322.002.77
Accounts Payable3.654.795.556.454.915.975.347.364.41
Income Tax Payable---0.000.220.290.610.980.40
Other Current Liabilities16.7812.0613.7110.8614.8010.9610.0411.176.47
Total Current Liabilities21.9654.9626.5423.2525.3221.0525.3121.5114.04
Long Term Debt42.756.3835.5048.3051.5853.7755.1458.808.98
Provision for Risks Charges0.000.000.000.000.000.000.750.881.15
Deferred Tax Liabilities0.320.710.780.591.561.901.972.302.65
Other Liabilities1.311.251.481.010.492.850.002.401.62
Total Liabilities66.3463.3064.2973.1478.9479.5783.1885.8928.45
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity13.7363.3473.0772.2283.4076.6881.6982.7280.90
Total Shareholders Equity13.7363.3473.0772.2283.4076.6881.6982.7280.90
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity13.7363.3473.0772.2283.4076.6881.6982.7280.90
Total Liabilities & Stockholders Equity80.07126.64137.37145.36162.34156.25164.87168.61109.35
Book Value Per Share3.0714.3716.8417.1620.2719.4621.3922.1323.10
Tangible Book Value Per Share-0.77-0.93-0.01-1.20-0.41-3.82-3.69-5.449.51
Full-Time Employees339355416455494459505547434
Price to Book Ratio8.671.473.071.603.482.201.431.441.50
Return on Assets-54.86-9.40-2.42-6.19-0.18-4.86-2.81-3.09-1.86
Return on Equity-147.13-18.19-4.70-12.23-0.36-9.86-5.70-5.25-2.63
Return on Invested Capital-100.38-17.79-3.15-7.90-0.21-5.99-3.43-2.95-0.96
Quick Ratio1.250.400.921.061.341.401.241.522.19
Current Ratio2.200.821.852.202.432.462.122.693.39

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-11.80-56.70-12.40-3.42-9.52-0.29-7.81-4.69-2.92
Depreciation5.035.957.167.007.587.627.637.737.83
Other Funds (Non Cash)5.4952.496.265.510.794.455.555.362.51
Funds from Operations-1.501.061.389.43-1.5611.455.228.004.56
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital1.375.670.074.602.72-10.194.110.04-1.68
Income Taxes Payable--------0.360.61
Cash from Operating Activities-0.126.731.4414.031.151.269.338.042.88
Capital Expenditures-3.48-1.86-3.26-2.31-1.59-1.34-1.15-1.22-1.01
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-68.55
Sale of Fixed Assets and Businesses0.000.000.000.510.000.000.001.0015.76
Purchase or Sale of Investments0.000.001.920.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.001.920.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00-0.25-0.010.00
Other Sources0.000.000.000.000.000.000.000.00-
Cash from Investing Activities-3.48-1.86-1.34-1.80-1.59-1.34-1.40-0.23-53.80
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.150.050.380.930.583.310.00-0.224.56
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00-0.220.00
Sale of Common Pref Stock0.150.050.380.930.583.310.000.004.56
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.004.56
Issuance or Reduction of Debt, Net1.82-1.180.07-10.54-1.79-0.05-6.89-7.4048.50
Change in Long Term Debt1.82-1.180.07-10.54-1.79-0.05-6.89-7.4048.50
Issuance of Long Term Debt36.1736.178.644.507.804.1560.024.3068.69
Reduction of Long Term Debt-34.35-37.35-8.57-15.04-9.59-4.20-66.91-11.70-20.20
Net Financing Active Other Cash Flow-0.17-0.16-0.58-2.52-1.63-3.51-1.070.000.00
Other Financing Activities Uses-0.17-0.16-0.58-2.52-1.63-3.51-1.070.000.00
Cash from Financing Activities1.80-1.29-0.13-12.13-2.84-0.25-7.97-7.6253.05
Exchange Rate Effect-0.160.93-0.14-0.32-0.04-0.160.02-0.030.30
Net Change in Cash-1.964.51-0.17-0.23-3.31-0.50-0.020.162.44
Free Cash Flow-2.625.47-1.2012.24-0.440.078.186.831.90
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-5.43-18.54-4,245.0520.2716.8961.08
Deferred Taxes & Investment Tax Credit--0.680.360.34-0.41-0.33-0.14-0.40-2.86

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments4.866.507.108.616.827.44
Short Term Receivables14.9114.5014.5716.0412.1111.94
Inventories23.4922.2322.2020.8021.6022.25
Other Current Assets2.723.233.602.763.273.33
Total Current Assets45.9846.4647.4848.2343.8044.97
Net Property, Plant & Equipment11.3811.7511.6011.9612.4912.04
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets15.4815.5516.2817.2017.9019.29
Deferred Tax Assets---3.50--
Other Assets2.462.532.58-0.813.793.79
Total Assets75.3076.2977.9480.0777.9980.09
Short Term Debt Incl. Current Port. of LT Debt1.701.601.551.5235.4536.32
Accounts Payable7.166.225.293.655.184.72
Other Current Liabilities17.2716.9717.0216.7813.7714.16
Total Current Liabilities26.1324.7923.8621.9654.4055.20
Long Term Debt42.5942.6142.5742.757.337.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.310.310.310.320.730.73
Other Liabilities1.161.161.151.311.461.43
Total Liabilities70.1968.8767.8966.3463.9264.36
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity5.117.4210.0513.7314.0715.73
Total Shareholders Equity5.117.4210.0513.7314.0715.73
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity5.117.4210.0513.7314.0715.73
Total Liabilities & Stockholders Equity75.3076.2977.9480.0777.9980.09
Book Value Per Share1.121.632.233.073.163.53
Tangible Book Value Per Share-2.27-1.79-1.38-0.77-0.86-0.80
Full-Time Employees---339--
Price to Book Ratio8.672.761.592.181.391.26
Return on Assets-15.40-13.32-12.41-54.86-51.46-54.93
Return on Equity-123.13-89.95-78.65-147.13-135.62-138.36
Return on Invested Capital-5.50-5.82-6.51-5.04-5.75-10.04
Quick Ratio0.860.981.061.250.410.41
Current Ratio1.761.871.992.200.810.81

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-2.62-2.91-3.42-2.85-1.23-2.28
Depreciation0.951.381.351.351.321.62
Other Funds (Non Cash)0.910.880.573.130.430.38
Funds from Operations-0.75-0.67-1.581.510.54-0.34
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.510.990.79-0.920.292.79
Cash from Operating Activities-0.250.32-0.790.590.832.45
Capital Expenditures-1.34-0.92-0.62-0.60-0.35-0.23
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-1.34-0.92-0.62-0.60-0.35-0.23
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.150.000.000.05
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.150.000.000.05
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.001.82-1.00-1.00
Change in Long Term Debt0.000.000.001.82-1.00-1.00
Issuance of Long Term Debt0.000.000.0036.170.000.00
Reduction of Long Term Debt0.000.000.00-34.35-1.00-1.00
Net Financing Active Other Cash Flow-0.04-0.04-0.03-0.06-0.020.00
Other Financing Activities Uses-0.04-0.04-0.03-0.06-0.020.00
Cash from Financing Activities-0.04-0.040.121.76-1.02-0.95
Exchange Rate Effect-0.010.03-0.230.04-0.080.63
Net Change in Cash-1.65-0.59-1.521.80-0.621.90
Free Cash Flow-1.18-0.36-1.220.140.622.36
Price to Free Cash Flow--11.405.452.894.46

Revenue breakdown

Instruments, Equipment, Software, and Accessories2024: 86.96M 2025: 78.26M
Service, Maintenance, and Warranty Contracts2024: 7.17M 2025: 8.29M
Americas, Other2024: 3.60M 2025: 3.23M
Asia, Other2024: 7.10M 2025: 6.68M
China2024: 13.30M 2025: 10.97M
EMEA2024: 28.41M 2025: 26.71M
United States2024: 41.74M 2025: 38.97M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.57%0.1M4.2M19.34K
2026-10-151.19%0.1M4.2M17.92K
2026-09-301.06%0.0M4.2M17.47K
2026-09-151.14%0.0M4.2M17.47K
2026-08-311.15%0.0M4.2M18.79K
2026-08-141.39%0.1M4.2M19.71K
2026-07-311.47%0.1M4.2M22.11K
2026-07-151.34%0.1M4.2M27.59K
2026-06-301.70%0.1M4.2M41.56K
2026-06-152.14%0.1M4.2M49.46K
2026-05-292.50%0.1M4.2M52.86K
2026-05-152.85%0.1M4.2M52.70K
2026-04-304.06%0.2M4.2M59.61K
2026-04-155.78%0.2M4.2M57.95K
2026-03-31-0.1M-47.15K
2026-03-13-0.0M-45.77K
2026-02-271.08%0.0M4.2M50.17K
2026-02-131.59%0.1M4.2M67.50K
2026-01-301.39%0.1M4.2M128.93K
2026-01-151.13%0.0M3.8M640.76K

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-09-22SCHEDULE 13G/ASEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-10S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-028-KCurrent report2026-06-02SEC
2026-05-27SDSpecialized Disclosure ReportSEC
2026-05-14SCHEDULE 13G/ASEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-04-21DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-21DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-02SEC
2026-04-014Statement of changes in beneficial ownership of securities2026-03-20SEC
2026-04-014Statement of changes in beneficial ownership of securities2026-03-16SEC
2026-03-234Statement of changes in beneficial ownership of securities2026-03-20SEC
2026-03-23SCHEDULE 13DSEC
2026-03-184Statement of changes in beneficial ownership of securities2026-03-17SEC
2026-03-184Statement of changes in beneficial ownership of securities2026-03-16SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-16SEC
2026-03-178-KCurrent report2026-03-17SEC
2026-03-1310-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-03202.35K500
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
WEBER CAPITAL MANAGEMENT LLC /ADV6.59%
Meros Investment Management, LP4.06%
ACADIAN ASSET MANAGEMENT LLC3.95%
VANGUARD CAPITAL MANAGEMENT LLC3.76%
NANO CAP NEW MILLENNIUM GROWTH FUND L P3.17%
CORSAIR CAPITAL MANAGEMENT, L.P.2.72%
TWO SIGMA INVESTMENTS, LP2.54%
RENAISSANCE TECHNOLOGIES LLC2.20%
BlackRock, Inc.1.37%
GEODE CAPITAL MANAGEMENT, LLC1.03%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.74%
VANGUARD EXTENDED MARKET INDEX FUND0.93%
Fidelity Extended Market Index Fund0.49%
ACUITAS US MICROCAP FUND0.30%
Fidelity Total Market Index Fund0.15%
Fidelity Series Total Market Index Fund0.13%
VANGUARD BALANCED INDEX FUND0.09%
Gabelli Global Mini Mites Fund0.09%
Dimensional US Sustainability Core 1 ETF0.04%
Fidelity Nasdaq Composite Index Fund0.04%

OakChart. HBIO. Cached 15 minutes.